Annual Long Term Debt
$33.20 M
-$2.80 M-7.78%
December 31, 2023
Summary
- As of February 7, 2025, SUPN annual long term debt is $33.20 million, with the most recent change of -$2.80 million (-7.78%) on December 31, 2023.
- During the last 3 years, SUPN annual long term debt has fallen by -$377.37 million (-91.91%).
- SUPN annual long term debt is now -92.11% below its all-time high of $420.55 million, reached on December 31, 2021.
Performance
SUPN Long Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Long Term Debt
$28.93 M
-$1.37 M-4.52%
September 30, 2024
Summary
- As of February 7, 2025, SUPN quarterly long term debt is $28.93 million, with the most recent change of -$1.37 million (-4.52%) on September 30, 2024.
- Over the past year, SUPN quarterly long term debt has dropped by -$4.92 million (-14.52%).
- SUPN quarterly long term debt is now -93.43% below its all-time high of $440.27 million, reached on March 31, 2022.
Performance
SUPN Quarterly Long Term Debt Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Long Term Debt Formula
Long-Term Debt = Bonds Payable + Long-Term Loans + Mortgage Payable + Other Long-Term Borrowings − Current Portion of Long-Term Debt
SUPN Long Term Debt Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -7.8% | -14.5% |
| 3 y3 years | -91.9% | -14.5% |
| 5 y5 years | -89.9% | -14.5% |
SUPN Long Term Debt Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -92.1% | at low | -93.4% | at low |
| 5 y | 5-year | -92.1% | at low | -93.4% | at low |
| alltime | all time | -92.1% | +697.0% | -93.4% | +1865.1% |
Supernus Pharmaceuticals Long Term Debt History
| Date | Annual | Quarterly |
|---|---|---|
| Sep 2024 | - | $28.93 M(-4.5%) |
| Jun 2024 | - | $30.29 M(-8.2%) |
| Mar 2024 | - | $32.99 M(-0.6%) |
| Dec 2023 | $33.20 M(-7.8%) | $33.20 M(-1.9%) |
| Sep 2023 | - | $33.84 M(-1.0%) |
| Jun 2023 | - | $34.18 M(-6.4%) |
| Mar 2023 | - | $36.51 M(+1.4%) |
| Dec 2022 | $36.00 M(-91.4%) | $36.00 M(-0.1%) |
| Sep 2022 | - | $36.03 M(-2.8%) |
| Jun 2022 | - | $37.08 M(-91.6%) |
| Mar 2022 | - | $440.27 M(+4.7%) |
| Dec 2021 | $420.55 M(+2.4%) | $420.55 M(+2.1%) |
| Sep 2021 | - | $412.05 M(+1.4%) |
| Jun 2021 | - | $406.53 M(-1.6%) |
| Mar 2021 | - | $413.07 M(+0.6%) |
| Dec 2020 | $410.56 M(+9.3%) | $410.56 M(+1.0%) |
| Sep 2020 | - | $406.33 M(+1.1%) |
| Jun 2020 | - | $401.84 M(+5.7%) |
| Mar 2020 | - | $380.04 M(+1.2%) |
| Dec 2019 | $375.61 M(+14.0%) | $375.61 M(+2.0%) |
| Sep 2019 | - | $368.42 M(+1.0%) |
| Jun 2019 | - | $364.75 M(+1.0%) |
| Mar 2019 | - | $361.13 M(+9.6%) |
| Dec 2018 | $329.46 M | $329.46 M(+1.2%) |
| Sep 2018 | - | $325.67 M(+1.2%) |
| Jun 2018 | - | $321.92 M(+1.2%) |
| Mar 2018 | - | $318.23 M(>+9900.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2017 | - | $1.47 M(-55.5%) |
| Mar 2017 | - | $3.31 M(-20.5%) |
| Dec 2016 | $4.17 M(-41.2%) | $4.17 M(-27.8%) |
| Sep 2016 | - | $5.77 M(+1.3%) |
| Jun 2016 | - | $5.70 M(+1.3%) |
| Mar 2016 | - | $5.63 M(-20.6%) |
| Dec 2015 | $7.08 M(-73.0%) | $7.08 M(-12.2%) |
| Sep 2015 | - | $8.07 M(-7.9%) |
| Jun 2015 | - | $8.76 M(-25.2%) |
| Mar 2015 | - | $11.71 M(-55.4%) |
| Dec 2014 | $26.22 M(-23.8%) | $26.22 M(-1.0%) |
| Sep 2014 | - | $26.50 M(-7.6%) |
| Jun 2014 | - | $28.67 M(+1.1%) |
| Mar 2014 | - | $28.36 M(-17.5%) |
| Dec 2013 | $34.39 M(+210.2%) | $34.39 M(-42.8%) |
| Sep 2013 | - | $60.17 M(+1.8%) |
| Jun 2013 | - | $59.10 M(+641.1%) |
| Mar 2013 | - | $7.97 M(-28.1%) |
| Dec 2012 | $11.09 M(-51.2%) | $11.09 M(-21.5%) |
| Sep 2012 | - | $14.12 M(-17.3%) |
| Jun 2012 | - | $17.06 M(-14.4%) |
| Mar 2012 | - | $19.93 M(-12.3%) |
| Dec 2011 | $22.71 M(-69.7%) | $22.71 M(-73.6%) |
| Sep 2011 | - | $86.01 M(+14.7%) |
| Sep 2010 | - | $75.00 M(0.0%) |
| Dec 2009 | $75.00 M(0.0%) | $75.00 M |
| Dec 2008 | $75.00 M | - |
FAQ
- What is Supernus Pharmaceuticals annual long term debt?
- What is the all time high annual long term debt for Supernus Pharmaceuticals?
- What is Supernus Pharmaceuticals annual long term debt year-on-year change?
- What is Supernus Pharmaceuticals quarterly long term debt?
- What is the all time high quarterly long term debt for Supernus Pharmaceuticals?
- What is Supernus Pharmaceuticals quarterly long term debt year-on-year change?
What is Supernus Pharmaceuticals annual long term debt?
The current annual long term debt of SUPN is $33.20 M
What is the all time high annual long term debt for Supernus Pharmaceuticals?
Supernus Pharmaceuticals all-time high annual long term debt is $420.55 M
What is Supernus Pharmaceuticals annual long term debt year-on-year change?
Over the past year, SUPN annual long term debt has changed by -$2.80 M (-7.78%)
What is Supernus Pharmaceuticals quarterly long term debt?
The current quarterly long term debt of SUPN is $28.93 M
What is the all time high quarterly long term debt for Supernus Pharmaceuticals?
Supernus Pharmaceuticals all-time high quarterly long term debt is $440.27 M
What is Supernus Pharmaceuticals quarterly long term debt year-on-year change?
Over the past year, SUPN quarterly long term debt has changed by -$4.92 M (-14.52%)